Vermillion, Inc.

Vermillion, Inc.

Vermillion, Inc.

Overview
Date Founded

2000

Headquarters

12117 Bee Caves Road,Building III,Suite 100,Austin, TX 78738

Type of Company

Public

Employees (Worldwide)

43

Industries

Medical Products & Equipment
Medical Support Services
Biotechnology

Company Description

Vermillion, Inc. engages in the provision of bio-analytic and diagnostic services. Its product, OVA1, is a serum test for identifying women of having malignant ovarian tumor. The company's bio-analytical solutions helps physicians diagnose, treat and improve gynecologic health outcomes for women. Vermillion was founded on December 9, 1993 and is headquartered in Austin, TX.

Contact Data
Trying to get in touch with decision makers at Vermillion, Inc.? Subscribe today to access their professional contact information and receive a one time promotion of free Contact Data credits!
Executives & Employees

Chief Financial Officer & Principal Accounting Officer

Global Medical Director

Senior Vice President of Commercial Operations

Vice President for Global Business Development & Managed Markets

Director of Sales Operations

Board of Directors

Professional at HTG Molecular Diagnostics, Inc.

Member, Leadership Team at The Boston Club, Inc.

Professional at Vermillion, Inc.

Director, President & Chief Executive Officer at Vermillion, Inc.

Professional at Response Genetics, Inc.

Paths to Vermillion, Inc.
Potential Connections via
Relationship Science
You
Vermillion, Inc.
Owners & Shareholders
Details Hidden

Oracle Investment Management focuses on long/short investments in the US healthcare sector with an emphasis on pharmaceutical and biotechnology companies. The firm tends to invest in small-cap US companies but they also invest in mid-cap and large-cap companies and in Europe. The firm seeks to achieve strong absolute and risk-adjusted returns on both client and principals capital by anticipating key sub-sector themes and by identifying specific companies within those sub-sectors with unrecognized investment potential. They use fundamental research in their stock selection and maintain a medium turnover rate

Details Hidden

Seamark Capital focused on publicly traded equities of dynamically growing companies and industries. The firm's sole investment offering is the Seamark Fund LP, a commingled investment partnership. The Seamark Fund invests long/short in publicly traded equities and the portfolio is primarily comprised of exchange-traded US growth companies, although non-US entities may be included.The Seamark Fund's primary investment objective is capital appreciation; current income is not an objective. The Fund targets established and emerging growth companies across all market-caps. although a substantial portion of the assets are invested in small- to mid-cap companies. Investments tend to include the securities of companies in the consumer, energy resources & services, financial services, healthcare-related products & services, and technology sectors.The Fund pursues two primary strategies: long-term capital appreciation and short-term, time-sensitive opportunities. Seamark Capital primarily uses proprietary fundamental analysis, and secondarily, technical and macroeconomic analysis, to identify and evaluate potential investments. The investment philosophy and strategy employed is often referred to as the \"Jones Model,\" which is a net-long biased, moderated volatility structure with an overall capital appreciation objective.

Details Hidden

Birchview Capital LP is an American private company located in Burlington, VT, with operations in US. The firm provides investment advice. It was founded in 2014 by Matthew William Strobeck, who has been the CEO since the company founding.

Recent Transactions
Details Hidden

Vermillion, Inc. issued Common Stock

Details Hidden

Vermillion, Inc. issued Common Stock

Details Hidden

Vermillion, Inc. raised money in a private placement transaction

Insider Transactions
Details Hidden
Transaction Advisors
Auditor

Advised onVermillion, Inc. issued Common Stock

Auditor

Advised onVermillion, Inc. issued Common Stock

Legal Advisor

Advised onVermillion, Inc. issued Common Stock

Legal Advisor

Advised onVermillion, Inc. issued Common Stock

Managing Director

Advised onVermillion, Inc. issued Common Stock

Legal Advisor

Advised onVermillion, Inc. issued Common Stock

Advisors & Consultants
Legal Advisor

Partner at Goodwin Procter LLP

Legal Advisor

Partner at Kramer Levin Naftalis & Frankel LLP

Legal Advisor

Managing Partner at DLA Piper

Clients

Quest Diagnostics, Inc. engages in the provision fo diagnostic testing, information and services. It operates through the Diagnostic Information Services (DIS) and All Other segments. The DIS segment offers diagnostic information services to patients, clinicians, hospitals, health plans, and employers. The All Other segment consists of risk assessment services, healthcare information technology, diagnostic products, and clinical trials testing businesses. The company was founded in 1967 and is headquartered in Secaucus, NJ.

Centene Corp. engages in the provision of programs and services to government sponsored healthcare programs. It operates through the Managed Care and Specialty Services segments. The Medicaid Managed Care segment provides health plan coverage to individuals through government subsidized programs through Medicaid. The Specialty Services segment offers healthcare services and products to state programs, correctional facilities, healthcare organizations, employer groups, and other commercial organizations. The company was founded in 1984 and is headquartered in St. Louis, MO.

WellCare Health Plans, Inc. engages in the provision of government-sponsored managed care services through Medicaid, Medicare Advantage, and Medicare Prescription Drug Plans to families, children, seniors, and individuals with complex medical needs. It operates through the following segments: Medicaid Health Plans, Medicare Health Plans, and Medicare PDPs. The Medicaid Health Plans segment includes plans for beneficiaries of TANF, SSI and ABD programs and other state-based programs that are not part of the Medicaid program, such as Children's Health Insurance Program and MLTC. The Medicare Health Plans segment provides a comprehensive array of Part C and Part D benefits to Medicare eligible persons, through the MA plans. The Medicare Prescription Drug Plans (PDP) segment serves as a plan sponsor offering stand-alone Medicare Part D PDP plans to Medicare-eligible beneficiaries through this segment. The company was founded in May 2002 and is headquartered in Tampa, FL.

Key Stats and Financials As of 2018
Market Capitalization
$99.7M
Total Enterprise Value
$13.1M
Earnings Per Share
$-0.16
Revenue
$3.05M
Net Profit
$-11.4M
EBITDA
$-10.7M
EBITDAMargin
-349.1%
Total Debt
$1.48M
Total Equity
$7.15M
Enterprise Value Sales
4.31x
TEVNet Income
-1.16x
Debt TEV
0.11x
Three Year Compounded Annual Growth Rate Of Revenue
11.93%
Five Year Compounded Annual Growth Rate Of Revenue
3.54%
Non-Profit Donations & Grants
Investments
Details Hidden

Multispan, Inc. develops assay tools for G-protein coupled receptor (GPCR) for research applications. It offers GPCR cell line reagents for drug screening assays, compound profiling, and monoclonal antibody generation. The firm also offers GPCR cDNA Bank that provides clones for GPCR expression in mammalian cells; and high expression cell lines, as well as cell line development services. The company was founded by Helena Suyang Mancebo and Jeng-Horng Her in 2004 and is headquartered in Hayward, CA.

Investors
Details Hidden

Bio-Rad Laboratories, Inc. engages in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. It operates through the following segments: Life Sciences and Clinical Diagnostics. The Life Science segment develops, manufactures and markets reagents, apparatus, and laboratory instruments. The Clinical Diagnostics segment designs, manufactures, sells and supports test systems, informatics systems, test kits and specialize in quality controls that serve clinical laboratories in the global diagnostics market. The company was founded by David S. Schwartz and Alice N. Schwartz in 1952 and is headquartered in Hercules, CA.

Details Hidden

Chief Investment Officer & Managing Partner at Birchview Capital LP

Details Hidden

Co-Founder at Crabtree Partners LLC

Suppliers
Roche Holding AG Medical Support Services | Basel, BS

Roche Holding ag Roche Personalised Healthcare – our mission The healthcare landscape is constantly changing. Patients, physicians and payers demand safer, more effective treatments, while investors search after robust and sustainable business models. Growing demand for highly effective, impactful medicines is being driven by an aging population, healthcare and economic pressures. But an influx of new technologies enables Roche to meet this need by offering innovative tests and medicines. These healthcare drivers have led us in one direction – ‘Roche Personalised Healthcare’. At Roche, ‘Personalised Healthcare’ is at the core of our business strategy

Quest Diagnostics, Inc. Hospitals & Patient Services | MADISON, NJ

Quest Diagnostics, Inc. engages in the provision fo diagnostic testing, information and services. It operates through the Diagnostic Information Services (DIS) and All Other segments. The DIS segment offers diagnostic information services to patients, clinicians, hospitals, health plans, and employers. The All Other segment consists of risk assessment services, healthcare information technology, diagnostic products, and clinical trials testing businesses. The company was founded in 1967 and is headquartered in Secaucus, NJ.

Siemens AG Computer Software | San Diego, CA

Siemens is a global powerhouse focusing on the areas of electrification, automation and digitalization. One of the world’s largest producers of energy-efficient, resource-saving technologies, Siemens is a leading supplier of systems for power generation and transmission as well as medical diagnosis. In infrastructure and industry solutions the company plays a pioneering role. As of September 30, 2015, we had around 348,000 employees in more than 200 countries. In fiscal 2015, they generated revenues of €75.6 billion.

Competitors
Abbott Laboratories Pharmaceuticals - Abbott Park, Illinois

Abbott Laboratories engages in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. It operates through the following segments: Established Pharmaceutical Products, Nutritional Products, Diagnostic Products, Cardiovascular and Neuromodulation Products, and Other. The Established Pharmaceutical Products segment refers to the international sales of a line of branded generic pharmaceutical products. The Nutritional Products segment caters to the worldwide sales of adult and pediatric nutritional products. The Diagnostic Products segment markets diagnostic systems and tests for blood banks, hospitals, commercial laboratories, and alternate-care testing sites. The Vascular Products segment trades coronary, endovascular, structural heart, vessel closure, and other medical device products. The Other segment comprises of Abbott Medical Optics. The company was founded by Wallace Calvin Abbott in 1888 and is headquartered in Abbott Park, IL.

Becton, Dickinson & Co. Medical Products & Equipment - Franklin Lakes, New Jersey

BD is a medical technology company that serves healthcare institutions, life science researchers, clinical laboratories, industry and the general public. BD manufactures and sells a broad range of medical supplies, devices, laboratory equipment and diagnostic products. BD is headquartered in the United States and has offices in more than 50 countries worldwide.

Miraca Holdings, Inc. Medical Support Services - Tokyo, TY

Miraca Holdings Inc. operates as a holding company which provides the strategic planning, investor relations, public relations, and supervisory management of the entire group. It operates through the following segments: In Vitro Diagnostics, Clinical Laboratory Testing, and Healthcare Related. The In Vitro Diagnostic segment offers clinical laboratory testing services; collecting consigned specimens of patients from medical institutions, conducting analyses and reporting the test results back. The Clinical Laboratory Testing segment develops, manufactures and sales diagnostic products globally that are used at medical field for early detection and diagnosis. The Healthcare Related segment provides various healthcare related services, such as sterilization, clinical trial support and preventive medicine related services. It also offers rental and sale of nursing care equipment and infection preventive products. The company was founded on December 18, 1950 and is headquartered in Tokyo, Japan.

This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by Vermillion, Inc.. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of Vermillion, Inc.'s profile does not indicate a business or promotional relationship of any kind between RelSci and Vermillion, Inc..
  • be_ixf; php_sdk; php_sdk_1.4.15
  • https://relationshipscience.com/organization/vermillion-inc-51032
  • https://relationshipscience.com/organization/vermillion-inc-51032